These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2144591)

  • 1. Quantitative structure-activity relationships of inhibitors of immune complex-induced inflammation: 1-phenyl-3-aminopyrazoline derivatives.
    Kim KH; Martin YC; Norris B; Young PR; Carter GW; Haviv F; Walters RL
    J Pharm Sci; 1990 Jul; 79(7):609-13. PubMed ID: 2144591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of immune complex-induced inflammation: 3-[1-(2-benzoxazolyl)hydrazino]propanenitrile derivatives.
    Kim KH; Martin YC; Norris B; Haviv F
    J Pharm Sci; 1989 Jun; 78(6):494-8. PubMed ID: 2527297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of immune complex-induced inflammation: 5-substituted 3-[1-(2-benzoxazolyl)hydrazino]propanenitrile derivatives.
    Kim KH; Martin YC; Young PR; Carter GW; Haviv F
    J Pharm Sci; 1990 Aug; 79(8):682-4. PubMed ID: 2146384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QSAR by LFER model of HIV protease inhibitor mannitol derivatives using FA-MLR, PCRA, and PLS techniques.
    Leonard JT; Roy K
    Bioorg Med Chem; 2006 Feb; 14(4):1039-46. PubMed ID: 16213730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and quantitative structure-activity relationships of diclofenac analogues.
    Moser P; Sallmann A; Wiesenberg I
    J Med Chem; 1990 Sep; 33(9):2358-68. PubMed ID: 2118185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSAR by LFER model of cytotoxicity data of anti-HIV 5-phenyl-1-phenylamino-1H-imidazole derivatives using principal component factor analysis and genetic function approximation.
    Roy K; Leonard JT
    Bioorg Med Chem; 2005 Apr; 13(8):2967-73. PubMed ID: 15781406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative structure-activity relationships of aromatic esters of 1-methyl-4-piperidinol as analgesics.
    Cheng CY; Brochmann-Hanssen E; Waters JA
    J Med Chem; 1982 Feb; 25(2):145-52. PubMed ID: 7057419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H3-receptor antagonists: synthesis and structure-activity relationships of para- and meta-substituted 4(5)-phenyl-2-[[2-[4(5)-imidazolyl]ethyl]thio]imidazoles.
    Mor M; Bordi F; Silva C; Rivara S; Crivori P; Plazzi PV; Ballabeni V; Caretta A; Barocelli E; Impicciatore M; Carrupt PA; Testa B
    J Med Chem; 1997 Aug; 40(16):2571-8. PubMed ID: 9258364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QSAR of matrix metalloproteinase inhibitor N-[(substituted phenyl)sulfonyl]-N-4-nitrobenzylglycine hydroxamates using LFER model.
    Roy K; Pal DK; De AU; Sengupta C
    Drug Des Discov; 2001; 17(4):315-23. PubMed ID: 11765134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octanol/water partition coefficient of ortho-substituted aromatic solutes.
    Sotomatsu T; Shigemura M; Murata Y; Fujita T
    J Pharm Sci; 1993 Aug; 82(8):776-81. PubMed ID: 8377112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quantitative structure-activity relationship study on some pyrazolo[4,5-c]quinolines acting as inhibitors of benzodiazepine-receptor binding.
    Gupta SP; Saha RN; Gupta JK; Singh P
    Res Commun Chem Pathol Pharmacol; 1989 Jul; 65(1):119-22. PubMed ID: 2551004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative structure-activity relationship and molecular graphics study of carbonic anhydrase inhibitors.
    Hansch C; McClarin J; Klein T; Langridge R
    Mol Pharmacol; 1985 May; 27(5):493-8. PubMed ID: 3990676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on anti-inflammatory agents. IV. Synthesis and pharmacological properties of 1,5-diarylpyrazoles and related derivatives.
    Tsuji K; Nakamura K; Konishi N; Tojo T; Ochi T; Senoh H; Matsuo M
    Chem Pharm Bull (Tokyo); 1997 Jun; 45(6):987-95. PubMed ID: 9214705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative structure-activity relationships of 5-lipoxygenase inhibitors. Inhibitory potency of pyridazinone analogues.
    Kim KH; Martin YC; Brooks DW; Dyer RD; Carter GW
    J Pharm Sci; 1994 Mar; 83(3):433-8. PubMed ID: 8207697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structure-activity relationship of 9-(X-phenyl)guanine inhibitors of xanthine oxidase.
    Silipo C; Hansch C
    Farmaco Sci; 1975 Jan; 30(1):35-46. PubMed ID: 1116591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-[1-(2-Benzoxazolyl)hydrazino]propanenitrile derivatives: inhibitors of immune complex induced inflammation.
    Haviv F; Ratajczyk JD; DeNet RW; Kerdesky FA; Walters RL; Schmidt SP; Holms JH; Young PR; Carter GW
    J Med Chem; 1988 Sep; 31(9):1719-28. PubMed ID: 2970549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure-activity relationship of phenoxy and benzyloxy acid derivatives as antisickling agents.
    Mahran MA
    Boll Chim Farm; 2000; 139(2):73-80. PubMed ID: 10920532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrophobicity parameter of diazines. II: Analysis and prediction of partition coefficients of disubstituted pyrazines.
    Yamagami C; Takao N; Fujita T
    J Pharm Sci; 1991 Aug; 80(8):772-7. PubMed ID: 1791539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of 1,2,4-benzotriazine 1,4-dioxides as hypoxia-selective analogues of tirapazamine.
    Hay MP; Gamage SA; Kovacs MS; Pruijn FB; Anderson RF; Patterson AV; Wilson WR; Brown JM; Denny WA
    J Med Chem; 2003 Jan; 46(1):169-82. PubMed ID: 12502371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative QSAR modeling of COX-2 inhibitor 1,2-diarylimidazoles using E-state and physicochemical parameters.
    Chakraborty S; Sengupta C; Roy K
    Indian J Biochem Biophys; 2007 Jun; 44(3):169-75. PubMed ID: 17650586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.